Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.

Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.

Ocular sebaceous carcinoma (OSC) is an uncommon malignancy with a potential to recur and metastasize. Some characteristics of sebaceous carcinoma, such as female preponderance, shown in the present series during 11-year period at Korea Cancer Center Hospital, led us to study their hormone receptors...

Full description

Bibliographic Details
Main Authors:	Cho, K. J., Khang, S. K., Koh, J. S., Chung, J. H., Lee, S. S.
Format:	Online
Language:	English
Published:	Korean Academy of Medical Sciences 2000
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054683/

Similar Items

Mucoepidermoid carcinoma of the salivary gland--a clinico-pathologic and immunohistochemical study for c-erbB-2 oncoprotein.
by: Cho, K. J., et al.
Published: (1997)

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
by: Lovekin, C., et al.
Published: (1991)

Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma.
by: Rasmuson, T., et al.
Published: (1997)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
by: Aasland, R., et al.
Published: (1988)

Prognostic significance of Helix pomatia lectin and c-erbB-2 oncoprotein in human breast cancer.
by: Thomas, M., et al.
Published: (1993)

Expression of c-erbB-2 protein in papillary thyroid carcinomas.
by: Haugen, D. R., et al.
Published: (1992)

Expression of c-erbB3 protein in primary breast carcinomas.
by: Naidu, R., et al.
Published: (1998)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
by: Colomer, R., et al.
Published: (1994)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
by: Li, Guangyuan, et al.
Published: (2014)

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
by: Poller, D. N., et al.
Published: (1993)

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
by: Parkes, H. C., et al.
Published: (1990)

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.
by: Barnes, D. M., et al.
Published: (1988)

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
by: Charpin, C., et al.
Published: (1997)

Sebaceous carcinoma of the eyelid diagnosed on fine needle aspiration cytology
by: Gill, Meenu, et al.
Published: (2012)

Advanced Upper Eyelid Sebaceous Gland Carcinoma with Deep Orbital Extension
by: Rizvi, Syed Ali Raza, et al.
Published: (2010)

c-erbB-2 oncogene as a prognostic marker in breast cancer.
by: Perren, T. J.
Published: (1991)

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
by: Gilbertson, R. J., et al.
Published: (1995)

c-erbB-3 protein expression in ovarian tumours.
by: Simpson, B. J., et al.
Published: (1995)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
by: Sutherland, Robert L
Published: (2011)

Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
by: Oh, Yoon Sin, et al.
Published: (2011)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
by: Benlimame, Naciba, et al.
Published: (2005)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
by: Singer, Josef, et al.
Published: (2012)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
by: Mizobuchi, Satoshi, et al.
Published: (2013)

ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism
by: GHOSH, ARUNDHATI, et al.
Published: (2012)

Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer
by: Ghasemi, R, et al.
Published: (2014)

Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography
by: Rasti, Mozhgan, et al.
Published: (2014)

c-erbB-2 expression in benign and malignant breast disease.
by: Gusterson, B. A., et al.
Published: (1988)

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
by: Pandya, K, et al.
Published: (2011)

Proteolytic Processing of ErbB4 in Breast Cancer
by: Hollmén, Maija, et al.
Published: (2012)

Expression of c-erbB-2 protein product in bladder cancer.
by: Wright, C., et al.
Published: (1990)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
by: Meng, Y, et al.
Published: (2016)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
by: Hubbard, A. L., et al.
Published: (1994)

Phosphotyrosine interactome of the ErbB-receptor kinase family
by: Schulze, Waltraud X, et al.
Published: (2005)

The interactome of human EGF/ErbB receptors
by: Uetz, Peter, et al.
Published: (2006)

The ErbB receptor tyrosine kinases and their roles in cancer
by: Hynes, NE
Published: (2003)

Pathway pathology: the wnt and erbB mammary tumors
by: Rosner, A, et al.
Published: (2001)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
by: Yao, Yong-Liang, et al.
Published: (2013)

c-erbB-3: a nuclear protein in mammary epithelial cells
by: Offterdinger, Martin, et al.
Published: (2002)

c-erbB-2 protein expression in astrocytic tumors of the brain
by: Reszeć, Joanna, et al.
Published: (2011)

Expression of MIF and c-erbB-2 in endometrial cancer
by: XIAO, WEI, et al.
Published: (2016)